Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Systematic Review of Safety and Cost-Effectiveness of Venous Thromboembolism Prophylaxis Strategies in Patients Undergoing Craniotomy for Brain Tumor.

Algattas H, Damania D, DeAndrea-Lazarus I, Kimmell KT, Marko NF, Walter KA, Vates GE, Jahromi BS.

Neurosurgery. 2018 Feb 1;82(2):142-154. doi: 10.1093/neuros/nyx156.

PMID:
28402497
2.

Aberrations in the Iron Regulatory Gene Signature Are Associated with Decreased Survival in Diffuse Infiltrating Gliomas.

Weston C, Klobusicky J, Weston J, Connor J, Toms SA, Marko NF.

PLoS One. 2016 Nov 29;11(11):e0166593. doi: 10.1371/journal.pone.0166593. eCollection 2016.

3.

Comparative Effectiveness Analysis of Treatment Options for Single Brain Metastasis.

Kimmell KT, LaSota E, Weil RJ, Marko NF.

World Neurosurg. 2015 Nov;84(5):1316-32. doi: 10.1016/j.wneu.2015.06.021. Epub 2015 Jun 20.

PMID:
26100168
4.

Multi-modal management of acromegaly: a value perspective.

Kimmell KT, Weil RJ, Marko NF.

Pituitary. 2015 Oct;18(5):658-65. doi: 10.1007/s11102-014-0626-1.

PMID:
25557288
5.

Preoperative imaging to predict intraoperative changes in tumor-to-corticospinal tract distance: an analysis of 45 cases using high-field intraoperative magnetic resonance imaging.

Shahar T, Rozovski U, Marko NF, Tummala S, Ziu M, Weinberg JS, Rao G, Kumar VA, Sawaya R, Prabhu SS.

Neurosurgery. 2014 Jul;75(1):23-30. doi: 10.1227/NEU.0000000000000338.

PMID:
24618800
6.

Extent of resection of glioblastoma revisited: personalized survival modeling facilitates more accurate survival prediction and supports a maximum-safe-resection approach to surgery.

Marko NF, Weil RJ, Schroeder JL, Lang FF, Suki D, Sawaya RE.

J Clin Oncol. 2014 Mar 10;32(8):774-82. doi: 10.1200/JCO.2013.51.8886. Epub 2014 Feb 10.

7.

Bevacizumab for radiation necrosis following treatment of high grade glioma: a systematic review of the literature.

Lubelski D, Abdullah KG, Weil RJ, Marko NF.

J Neurooncol. 2013 Dec;115(3):317-22. doi: 10.1007/s11060-013-1233-0. Epub 2013 Sep 5. Review.

PMID:
24005770
8.

Introduction to the Genomics special edition on clinical and translational genomics.

Marko NF.

Genomics. 2013 Aug;102(2):73. doi: 10.1016/j.ygeno.2013.07.004. No abstract available.

9.

The cancer megafund: determinants of success.

Marko NF.

Nat Biotechnol. 2013 Jun;31(6):492-4. doi: 10.1038/nbt.2603. No abstract available.

PMID:
23752428
10.

Cerebral radiation necrosis: a review of the pathobiology, diagnosis and management considerations.

Rahmathulla G, Marko NF, Weil RJ.

J Clin Neurosci. 2013 Apr;20(4):485-502. doi: 10.1016/j.jocn.2012.09.011. Epub 2013 Feb 14. Review.

PMID:
23416129
11.

The molecular biology of WHO grade II gliomas.

Marko NF, Weil RJ.

Neurosurg Focus. 2013 Feb;34(2):E1. doi: 10.3171/2012.12.FOCUS12283. Review.

PMID:
23373446
12.

Relapsing, remitting hypercortisolism in Cushing's disease due to intratumoral hemorrhages in pituitary microadenoma.

Marko NF, Hamrahian AH, Hatipoglu B, Weil RJ.

J Clin Neurosci. 2013 May;20(5):753-6. doi: 10.1016/j.jocn.2012.05.039. Epub 2013 Jan 24.

PMID:
23352667
13.

Role of Gamma Knife surgery in patients with 5 or more brain metastases.

Mohammadi AM, Recinos PF, Barnett GH, Weil RJ, Vogelbaum MA, Chao ST, Suh JH, Marko NF, Elson P, Neyman G, Angelov L.

J Neurosurg. 2012 Dec;117 Suppl:5-12. doi: 10.3171/2012.8.GKS12983.

PMID:
23205782
14.
15.

The molecular biology of WHO grade I astrocytomas.

Marko NF, Weil RJ.

Neuro Oncol. 2012 Dec;14(12):1424-31. doi: 10.1093/neuonc/nos257. Epub 2012 Oct 22. Review.

16.

Sellar mass with vision loss and hypopituitarism.

Marko NF, Prayson RA, Weil RJ.

J Clin Neurosci. 2012 Sep;19(9):1282; answer 1331. No abstract available.

PMID:
23050268
17.

Towards an integrated molecular and clinical strategy to predict early recurrence in surgically resected non-functional pituitary adenomas.

Marko NF, Coughlan C, Weil RJ.

J Clin Neurosci. 2012 Nov;19(11):1535-40. doi: 10.1016/j.jocn.2012.01.038. Epub 2012 Sep 17.

PMID:
22995758
18.

Pituitary gland: New pathways in the pathogenesis of pituitary adenomas.

Marko NF, Weil RJ.

Nat Rev Endocrinol. 2012 Oct;8(10):572-3. doi: 10.1038/nrendo.2012.143. Epub 2012 Aug 7. No abstract available.

PMID:
22869361
19.

A case for reclassifying infiltrating gliomas in adults.

Marko NF, Weil RJ.

J Neurooncol. 2012 Sep;109(3):587-91. doi: 10.1007/s11060-012-0928-y. Epub 2012 Jul 20. No abstract available.

PMID:
22814861
20.

Comparative effectiveness research in neurosurgery.

Marko NF, Weil RJ.

Neurosurg Focus. 2012 Jul;33(1):2 prior to E1. doi: 10.3171/2012.6.FOCUS12223. No abstract available.

PMID:
22746242
21.
22.

Comparative effectiveness review of treatment options for pituitary microadenomas in acromegaly.

Marko NF, LaSota E, Hamrahian AH, Weil RJ.

J Neurosurg. 2012 Sep;117(3):522-38. doi: 10.3171/2012.4.JNS11739. Epub 2012 Jun 22. Review.

PMID:
22725987
23.

Hyperosmolar therapy for intracranial hypertension: time to dispel antiquated myths.

Marko NF.

Am J Respir Crit Care Med. 2012 Mar 1;185(5):467-8. doi: 10.1164/rccm.201109-1698ED. No abstract available.

PMID:
22383562
24.
25.

Predicting survival in women with breast cancer and brain metastasis: a nomogram outperforms current survival prediction models.

Marko NF, Xu Z, Gao T, Kattan MW, Weil RJ.

Cancer. 2012 Aug 1;118(15):3749-57. doi: 10.1002/cncr.26716. Epub 2011 Dec 16.

26.

Hyperosmolar therapy for intracranial hypertension.

Torre-Healy A, Marko NF, Weil RJ.

Neurocrit Care. 2012 Aug;17(1):117-30. doi: 10.1007/s12028-011-9649-x. Review.

PMID:
22090171
27.

Relationship between HER2 status and prognosis in women with brain metastases from breast cancer.

Xu Z, Marko NF, Chao ST, Angelov L, Vogelbaum MA, Suh JH, Barnett GH, Weil RJ.

Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):e739-47. doi: 10.1016/j.ijrobp.2011.06.1968. Epub 2011 Oct 22.

PMID:
22024205
28.

Impact of preexisting tumor necrosis on the efficacy of stereotactic radiosurgery in the treatment of brain metastases in women with breast cancer.

Xu Z, Marko NF, Angelov L, Barnett GH, Chao ST, Vogelbaum MA, Suh JH, Weil RJ.

Cancer. 2012 Mar 1;118(5):1323-33. doi: 10.1002/cncr.26314. Epub 2011 Aug 25.

29.

An introduction to comparative effectiveness research.

Marko NF, Weil RJ.

Neurosurgery. 2012 Feb;70(2):425-34; discussion 434. doi: 10.1227/NEU.0b013e3182320a9e. Review.

PMID:
21849923
30.
31.

Stereotactic radiosurgical treatment of brain metastases to the choroid plexus.

Siomin V, Lin JL, Marko NF, Barnett GH, Toms SA, Chao ST, Angelov L, Vogelbaum MA, Navaratne K, Suh JH, Weil RJ.

Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):1134-42. doi: 10.1016/j.ijrobp.2010.03.016.

PMID:
21683888
32.

Medical oncology: Patients with brain metastases in early-phase trials.

Marko NF, Weil RJ.

Nat Rev Clin Oncol. 2011 May 17;8(7):390-1. doi: 10.1038/nrclinonc.2011.73. No abstract available.

PMID:
21587217
33.

Gamma knife stereotactic radiosurgery for the management of incidentally-identified brain metastasis from non-small cell lung cancer.

Marko NF, Suh JH, Chao ST, Barnett GH, Vogelbaum MA, Toms S, Weil RJ, Angelov L.

J Neurooncol. 2011 Sep;104(3):817-24. doi: 10.1007/s11060-011-0553-1. Epub 2011 Mar 23.

PMID:
21431468
34.

A comparative effectiveness analysis of alternative strategies to assess hypothalamic-pituitary-adrenal axis function after microsurgical resection of pituitary tumors.

Marko NF, Weil RJ.

Neurosurgery. 2011 Jun;68(6):1576-84; discussion 1585. doi: 10.1227/NEU.0b013e31820cd45a.

PMID:
21311380
35.

The role of observational investigations in comparative effectiveness research.

Marko NF, Weil RJ.

Value Health. 2010 Dec;13(8):989-97. doi: 10.1111/j.1524-4733.2010.00786.x. Review.

36.

Mathematical modeling of molecular data in translational medicine: theoretical considerations.

Marko NF, Weil RJ.

Sci Transl Med. 2010 Nov 3;2(56):56rv4. doi: 10.1126/scitranslmed.3001207. Review.

PMID:
21048218
37.

Stereotactic radiosurgery as single-modality treatment of incidentally identified renal cell carcinoma brain metastases.

Marko NF, Angelov L, Toms SA, Suh JH, Chao ST, Vogelbaum MA, Barnett GH, Weil RJ.

World Neurosurg. 2010 Mar;73(3):186-93; discussion e29. doi: 10.1016/j.surneu.2009.02.011. Epub 2009 Jul 15.

PMID:
20860956
38.

Surgery: Remission after transsphenoidal surgery for Cushing disease.

Marko NF, Weil RJ.

Nat Rev Endocrinol. 2010 Jun;6(6):307-9. doi: 10.1038/nrendo.2010.67. No abstract available.

PMID:
20502466
39.

Radiotherapy: Neurocognitive considerations in the treatment of brain metastases.

Marko NF, Weil RJ.

Nat Rev Clin Oncol. 2010 Apr;7(4):185-6. doi: 10.1038/nrclinonc.2010.30.

PMID:
20354539
40.
41.

Integrated molecular analysis suggests a three-class model for low-grade gliomas: a proof-of-concept study.

Marko NF, Prayson RA, Barnett GH, Weil RJ.

Genomics. 2010 Jan;95(1):16-24. doi: 10.1016/j.ygeno.2009.09.007. Epub 2009 Oct 14.

42.

Use of morning serum cortisol level after transsphenoidal resection of pituitary adenoma to predict the need for long-term glucocorticoid supplementation.

Marko NF, Gonugunta VA, Hamrahian AH, Usmani A, Mayberg MR, Weil RJ.

J Neurosurg. 2009 Sep;111(3):540-4. doi: 10.3171/2008.12.JNS081265.

PMID:
19326985
43.

Genomic expression patterns distinguish long-term from short-term glioblastoma survivors: a preliminary feasibility study.

Marko NF, Toms SA, Barnett GH, Weil R.

Genomics. 2008 May;91(5):395-406. doi: 10.1016/j.ygeno.2008.01.002. Epub 2008 Mar 17.

44.

Nanotechnology in proteomics.

Marko NF, Weil RJ, Toms SA.

Expert Rev Proteomics. 2007 Oct;4(5):617-26. Review.

PMID:
17941817
45.

A robust method for the amplification of RNA in the sense orientation.

Marko NF, Frank B, Quackenbush J, Lee NH.

BMC Genomics. 2005 Mar 1;6:27.

46.

Functional outcomes and survival in patients with high-grade gliomas in dominant and nondominant hemispheres.

Polin RS, Marko NF, Ammerman MD, Shaffrey ME, Huang W, Anderson FA Jr, Caputy AJ, Laws ER.

J Neurosurg. 2005 Feb;102(2):276-83.

PMID:
15739555
47.

Supplemental Content

Loading ...
Support Center